#anticholinergic tablets | Explore Tumblr posts and blogs

harshnews · 1 month ago

Text

Functional Bowel Disorder Agents Market Size, Share, Demand, Future Growth, Challenges and Competitive Analysis

"Functional Bowel Disorder Agents Market – Industry Trends and Forecast to 2029

Global Functional Bowel Disorder Agents Market, By Drug Class (Anticholinergics, Chloride Channel Activators, Guanylate Cyclase-C Agonists, NHE3 Inhibitors, Peripheral Opioid Receptor Antagonists, Peripheral Opioid Receptor Mixed Agonists/Antagonists, Serotoninergic Neuroenteric Modulators), Application (Irritable Bowel Syndrome, Chronic Bloating, Diarrhea, Constipation, Others), Dosage (Injection, Tablet, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- By Drug Type: Laxatives, Antidiarrheal Agents, Antispasmodics, Others - By Disease Type: Irritable Bowel Syndrome (IBS), Functional Constipation, Functional Diarrhea, Others - By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The market for functional bowel disorder agents is segmented by drug type, disease type, and distribution channel. In terms of drug type, the market is divided into laxatives, antidiarrheal agents, antispasmodics, and others. Laxatives are commonly used to treat constipation, antidiarrheal agents for diarrhea, and antispasmodics for abdominal pain and cramping associated with bowel disorders. The disease type segment includes irritable bowel syndrome (IBS), functional constipation, functional diarrhea, and others. IBS is a common disorder affecting the large intestine, leading to symptoms like cramping, abdominal pain, bloating, gas, diarrhea, and constipation. Functional constipation and diarrhea are conditions where bowel movements are not smooth and regular. Distribution channels for these agents include hospital pharmacies, retail pharmacies, and online pharmacies, providing accessibility to a wide range of consumers.

**Market Players**

- Allergan - Takeda Pharmaceutical Company Limited - Astellas Pharma Inc. - GlaxoSmithKline plc - AstraZeneca - Bayer AG - Sebela Pharmaceuticals Inc. - Takeda Pharmaceuticals U.S.A., Inc. - Sucampo Pharmaceuticals (U.S.) - Ironwood Pharmaceuticals, Inc.

Key market players in the functional bowel disorder agents market include Allergan, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., GlaxoSmithKline plc, AstraZeneca, Bayer AG, Sebela Pharmaceuticals Inc., Takeda Pharmaceuticals U.S.A., Inc., Sucampo Pharmaceuticals (U.S.), and Ironwood Pharmaceuticals, Inc.The market for functional bowel disorder agents is highly competitive, with key players striving to gain a significant market share through product innovation, strategic partnerships, mergers, acquisitions, and geographical expansion. Allergan is a prominent player with a diverse portfolio of gastrointestinal products, including treatments for irritable bowel syndrome and constipation. Takeda Pharmaceutical Company Limited focuses on research and development to introduce novel therapies for functional bowel disorders. Astellas Pharma Inc. has a strong presence in the market, offering a range of antispasmodic agents for managing symptoms associated with bowel disorders.

GlaxoSmithKline plc and AstraZeneca are global pharmaceutical giants that have made significant investments in developing and commercializing medications for gastrointestinal conditions. Bayer AG is known for its expertise in healthcare and offers a wide range of products for gastrointestinal disorders. Sebela Pharmaceuticals Inc. specializes in gastrointestinal therapies and has a dedicated focus on providing effective solutions for functional bowel disorders. Takeda Pharmaceuticals U.S.A., Inc. is a subsidiary of Takeda Pharmaceutical Company Limited and plays a vital role in marketing and distributing gastrointestinal products in the U.S. market.

Sucampo Pharmaceuticals (U.S.) is known for its research in gastrointestinal diseases and has brought forth innovative treatment options for functional bowel disorders. Ironwood Pharmaceuticals, Inc. is a key player that has developed multiple medications for various gastrointestinal conditions, contributing to the overall growth of the market. These market players compete on the basis of product quality, efficacy, safety, pricing, and distribution channels to cater to the diverse needs of patients suffering from functional bowel disorders.

The functional bowel disorder agents market is driven by factors such as the increasing prevalence of gastrointestinal diseases, changing dietary habits, sedentary lifestyles, and the rising awareness among consumers about treatment options. Market players are focusing on expanding their product portfolios, conducting clinical trials, and collaborating with healthcare providers to enhance patient outcomes. Moreover, the growing geriatric population, who are more prone to gastrointestinal issues, is also driving the demand**Global Functional Bowel Disorder Agents Market, By Drug Class** - Anticholinergics - Chloride Channel Activators - Guanylate Cyclase-C Agonists - NHE3 Inhibitors - Peripheral Opioid Receptor Antagonists - Peripheral Opioid Receptor Mixed Agonists/Antagonists - Serotoninergic Neuroenteric Modulators

The global functional bowel disorder agents market is witnessing significant growth driven by various factors. The market segmentation by drug class includes a wide range of medications such as anticholinergics, chloride channel activators, guanylate cyclase-C agonists, NHE3 inhibitors, peripheral opioid receptor antagonists, peripheral opioid receptor mixed agonists/antagonists, and serotoninergic neuroenteric modulators. This diverse range of drug classes allows healthcare providers to address different symptoms and conditions associated with functional bowel disorders effectively. The application segment encompasses irritable bowel syndrome, chronic bloating, diarrhea, constipation, and others, reflecting the broad spectrum of conditions that these agents can target. The dosage forms include injections, tablets, and others, providing flexibility in treatment options for patients. Moreover, the route of administration includes oral, intravenous, and others, offering various options for healthcare providers to administer medications based on patient needs.

In terms of end-users, hospitals, specialty clinics, homecare settings, and others play a crucial role in ensuring access to these medications for patients suffering from functional bowel

Functional Bowel Disorder Agents Key Benefits over Global Competitors:

The report provides a qualitative and quantitative analysis of the Functional Bowel Disorder Agents Market trends, forecasts, and market size to determine new opportunities.

Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.

Top impacting factors & major investment pockets are highlighted in the research.

The major countries in each region are analyzed and their revenue contribution is mentioned.

The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients

Table of Contents: Functional Bowel Disorder Agents Market

1 Introduction

2 Global Functional Bowel Disorder Agents Market Segmentation

3 Executive Summary

4 Premium Insight

5 Market Overview

6 Functional Bowel Disorder Agents Market, by Product Type

7 Functional Bowel Disorder Agents Market, by Modality

8 Functional Bowel Disorder Agents Market, by Type

9 Functional Bowel Disorder Agents Market, by Mode

10 Functional Bowel Disorder Agents Market, by End User

12 Functional Bowel Disorder Agents Market, by Geography

12 Functional Bowel Disorder Agents Market, Company Landscape

13 Swot Analysis

14 Company Profiles

Critical Insights Related to the Keyword Included in the Report:

Exclusive graphics and Illustrative Porter’s Five Forces analysis of some of the leading companies in this market

Value chain analysis of prominent players in the market

Current trends influencing the dynamics of this market across various geographies

Recent mergers, acquisitions, collaborations, and partnerships

Revenue growth of this industry over the forecast period

Marketing strategy study and growth trends

Growth-driven factor analysis

Emerging recess segments and region-wise market

An empirical evaluation of the curve of this market

Ancient, Present, and Probable scope of the market from both prospect value and volume

Browse Trending Reports:

Asia Pacific Mainframe Market

Asia Pacific Menstrual Cramps Treatment Market

Europe Commercial Cleaning Equipment Market

Europe Mainframe Market

Europe Quantum Computing Market

Europe Tomatoes Market

Europe Utility Locator Market

India Blood Gas Analyzer Market

Middle East And Africa Commercial Cleaning Equipment Market

Middle East And Africa Neurosurgery Market

Middle East And Africa Sports Medicine Market

Middle East And Africa Vaccines Market

Nigeria Cassava Starch Market

Nigeria Starch Processing Market

North America Menstrual Cramps Treatment Market

North America Neurosurgery Market

West Africa Baby Food Market

Antenna Market

Baby Apparel Market

Cassava Starch Market

Castor Oil Market

Cenospheres Market

Coconut Water Market

Collagen Casings Market

Facility Management Market

Functional Confectionery Market

Hemp Seed Market

Infrared Imaging Market

Instant Noodles Market

Laundry Detergents Market

Menstrual Cramps Treatment Market

Micro And Nano Plc Market

Motorcycle Market

Neurosurgery Market

Nickel Alloy Market

Over The Counter Probiotic Supplements Market

Polycystic Kidney Disease Adpkd Market

Private Label Food And Beverage Market

Recreational Cannabis Market

Tofu And Tempeh Market

Tomatoes Market

Vaccines Market

Varnish Makers Market

Wireless Medical Device Connectivity Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: [email protected]"

#Functional Bowel Disorder Agents Market

0 notes

credenceresearchdotblog · 3 months ago

Text

The Cord Blood Product Market is projected to grow from USD 834.19 million in 2024 to USD 1,198.15 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.63%.The global pharmaceutical landscape is vast and dynamic, with various segments witnessing growth driven by innovation, demand, and changing consumer health needs. One such segment is the Hydroxyzine market. Hydroxyzine, an antihistamine with anticholinergic and sedative properties, is primarily used to treat allergy symptoms, anxiety, and nausea, and as a preoperative sedative. This article explores the current state of the Hydroxyzine market, its growth drivers, challenges, and future outlook.

Browse the full report at https://www.credenceresearch.com/report/cord-blood-product-market

Market Overview

The Hydroxyzine market is an essential part of the global pharmaceutical sector, driven by its widespread use in treating a variety of conditions. Hydroxyzine is available in several forms, including tablets, capsules, syrups, and injections, making it a versatile drug for different age groups and medical needs. The market encompasses both generic and brand-name versions, with generic drugs being more prevalent due to cost-effectiveness.

In recent years, the demand for Hydroxyzine has been steadily increasing, owing to its broad therapeutic applications. The drug is commonly prescribed for managing anxiety, a condition that has seen a significant rise globally due to increasing stress levels in modern life. Additionally, its use in allergy treatment contributes to its market demand, particularly during allergy seasons.

Market Drivers

Several factors contribute to the growth of the Hydroxyzine market:

1. Rising Prevalence of Anxiety and Allergic Conditions: The global increase in anxiety disorders and allergic reactions has fueled the demand for Hydroxyzine. With mental health gaining more attention, Hydroxyzine's role as an anxiolytic is particularly significant. The World Health Organization (WHO) estimates that nearly 264 million people worldwide suffer from anxiety disorders, many of whom benefit from medications like Hydroxyzine.

2. Expansion of Healthcare Infrastructure: The ongoing expansion and improvement of healthcare infrastructure in emerging economies have made medications like Hydroxyzine more accessible. Governments and private sectors in countries like India, China, and Brazil are investing heavily in healthcare, which is expected to boost the availability and sales of Hydroxyzine.

3. Generic Drug Market Growth: The patent expiration of many brand-name drugs has led to the proliferation of generic versions. Generic Hydroxyzine is widely available and affordable, driving its adoption across various regions. The cost-effectiveness of generics makes them a preferred choice for both patients and healthcare providers, further propelling market growth.

4. Increased Awareness and Diagnosis: Growing awareness about mental health and allergic conditions, along with improved diagnostic techniques, has led to more prescriptions of Hydroxyzine. Early diagnosis and treatment are crucial, and Hydroxyzine's effectiveness in managing symptoms makes it a popular choice among healthcare professionals.

Challenges Facing the Market

Despite its growth prospects, the Hydroxyzine market faces several challenges:

1. Side Effects and Alternatives: Like many medications, Hydroxyzine is associated with side effects such as drowsiness, dry mouth, and blurred vision. These side effects can limit its use, particularly in patients who need to remain alert. Additionally, the availability of alternative medications with fewer side effects poses a challenge to Hydroxyzine's market share.

2. Regulatory Hurdles: The pharmaceutical industry is heavily regulated, and Hydroxyzine is no exception. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent requirements for drug approval and monitoring. Any adverse findings or changes in regulations can impact the market negatively.

3. Patent Expirations: While generic drugs drive market growth, the expiration of patents for brand-name drugs can lead to market saturation, resulting in price wars and reduced profit margins for manufacturers.

Future Outlook

The Hydroxyzine market is poised for continued growth in the coming years, driven by the rising prevalence of anxiety disorders and allergies, the expansion of healthcare infrastructure, and the increasing adoption of generic drugs. However, the market must navigate challenges such as side effects, regulatory hurdles, and competition from alternative medications.

Innovation in drug formulation and delivery methods, along with ongoing research into Hydroxyzine's therapeutic potential, could unlock new opportunities for growth. Additionally, the increasing focus on mental health globally presents a significant market opportunity for Hydroxyzine as an anxiolytic.

Key Player Analysis

ViaCord PerkinElmer (Revvity)

LifeCell International Pvt. Ltd.

Cordlife Group Ltd.

Cryo-Cell International, Inc.

StemCyte, Inc.

CryoHoldco

CBR Systems, Inc.

Maze Cord Blood Laboratories

Cells4Life Group LLP

Vita34 AG

CariCord, Inc.

Cryo-Save AG

Esperite N.V.

CORD BLOOD AMERICA, INC.

NeoStem, Inc.

Segments:

Based on Product Type:

Cord Blood-Derived Growth Factors

Cord Blood Cell Therapy Products

Cord Blood Units

Based on Therapeutic Area:

Oncology

Hematology

Immunology

Metabolic Disorders

Others

Based on Storage Status:

Fresh Cord Blood Products

Frozen Cord Blood Units

Cryopreserved Cord Blood Products

Based on Application:

Transplantation

Regenerative Medicine

Others

Based on End-user:

Hospitals

Cord Blood Banks

Academic and Research Institutes

Specialty Clinics

Based on the Geography:

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/cord-blood-product-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

sparklyeevee · 6 months ago

Text

Approximating Common OTC Combination Medicines With Non-Combination Meds

Contains notes on what each ingredient is meant to do, and the most common reasons you might want to avoid it.

Excedrin extra-strength or Excedrin Migraine (per usual 2 tablet dose)

One extra-strength (500mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1.5 regular aspirin (325mg), OR six "low dose" (81mg aspirin), OR one extra-strength or "back and body" aspirin (500mg). You're going for about 500mg but aspirin doses are arcane. NSAID pain reliever, fever reducer, antiinflammatory, salicylate, blood thinner, hard on the stomach.

2 cups of black or green tea OR one cup of brewed coffee OR a coffee drink with two shots of espresso OR 2tsp instant coffee crystals (you can turn it into liquid coffee or not) OR half a standard caffeine pill OR a 100mg caffeine pill if you can find them. 100-150mg of caffeine. Stimulant, vasoconstrictor, diuretic, increases heart rate, iirc works synergistically with the pain relievers.

Excedrin PM (per usual 2 tablet dose)

One extra-strength (500mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1.5 regular aspirin (325mg per tablet), OR six "low dose" (81mg aspirin per tablet), OR one extra-strength or "back and body" aspirin (500mg). You're going for about 500mg but aspirin doses are arcane. NSAID pain reliever, fever reducer, antiinflammatory, salicylate, blood thinner, hard on the stomach.

2 diphenhydramine hcl tablets (Benadryl, Sominex, or Unisom Sleep Gels) (25mg per tablet, 50mg total) - antihistamine, sleep aid, anticholinergic, dehydrating.

Note: Excedrin PM container 38mg per tablet of diphenhydramine citrate, not HCL. 25mg diphenhydramine hcl is equivalent. Diphenhydramine citrate is extraordinarily difficult to find outside of combination medicines. If for some reason you must have the citrate, do not take the aspirin and combine 1 extra strength acetaminophen with 2 tablets of combined ibuprofen (200mg) and diphenhydramine citrate (38mg), typically marketed as Advil pm or ibuprofen pm.

NyQuil (per typical 2 gel cap dose or 30ml of liquid medicine)

2 regular (325mg per tablet, 650mg total) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

2 gel caps (15mg each, 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 half tablet (25mg per tablet, 12.5mg total) doxylamine succinate (unisom sleep tabs) - sleep aid, antihistamine, anticholinergic, dehydrating.

Note 1: dextromethorphan by itself is a right pain to find these days. If you tolerate guaifenesin, a single tablet of 30mg dextromethorphan and 600mg guaifenesin will serve your purposes as well as or better than dextromethorphan by itself.

Note 2: Look, I fucking hate NyQuil, okay? It's terrible. Doxylamine succinate is an objectively worse drug than diphenhydramine unless you're specifically trying to sleep for 12+ hours, dextromethorphan is less useful without guaifenesin, and that's probably more acetaminophen than you need. My advice is to take 500mg acetaminophen (1 extra strength tablet), 1 tablet of combined dextromethorphan and guaifenesin (30/600, so the coughing you do anyway will be productive), and 25mg of diphenhydramine hcl (if you actually want the sleep aid).

NyQuil Severe

2 regular (325mg per tablet, 650mg total) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 or 2 gel caps (15mg each, 15 or 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 half tablet (25mg per tablet, 12.5mg total) doxylamine succinate (unisom sleep tabs) - sleep aid, antihistamine, anticholinergic, dehydrating.

1 tablet (15mg) pseudoephedrine - decongestant, mild stimulant, increases heart rate and blood pressure.

Note 1: see NyQuil above for notes on dextromethorphan and how much I hate NyQuil.

Note 2: Yeah I straight up replaced the phenylephrine with a different drug because oral phenylephrine doesn't work as a decongestant. This has been confirmed repeatedly. It doesn't fucking work. If you can't access, or can't take, pseudoephedrine, guaifenesin will help some, and so will maybe a warm cup of tea. If you insist on taking phenylephrine anyway, you're looking for a single 10mg tablet.

Note 3: this stuff contains 20mg dextromethorphan per dose, which doesn't seem to exist elsewhere. If you have a bad cough, take 2 15s, if you have a mild or occasional cough, take 1, if you don't have a cough, keep 1 handy but don't take it if you don't need it.

DayQuil (per 2 gelcaps or 30ml liquid)

2 regular (325mg per tablet, 650mg total) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 or 2 gel caps (15mg each, 15 or 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 tablet (15mg) pseudoephedrine - decongestant, mild stimulant, increases heart rate and blood pressure.

Note 1: see note 1 on NyQuil for more on dextromethorphan logistics, note 2 on NyQuil Severe for more on replacement of phenylephrine with pseudoephedrine, and note 3 on NyQuil Severe for even more dextromethorphan logistics.

DayQuil Severe

2 regular (325mg per tablet, 650mg total) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 or 2 gel caps (15mg each, 15 or 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 half tablet (600mg/tablet, 300mg total) guaifenesin - mucus thinner.

1 tablet (15mg) pseudoephedrine - decongestant, mild stimulant, increases heart rate and blood pressure.

Note 1: there's 400mg of guaifenesin in a normal dose of DayQuil Severe, but tablets below 600mg are hard to find. 600mg is probably fine. You can also replace the dextromethorphan gels and guaifenesin tablet with a whole or half tablet of dextromethorphan 30mg/guaifenesin 600mg.

See note 2 on NyQuil Severe for more on replacement of phenylephrine with pseudoephedrine, and notes 1 and 3 on NyQuil Severe for more on dextromethorphan logistics.

Pamprin Multi-Sympton Maximum Strength

One extra-strength (500mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 tablet (50mg) pamabrom (diurex) - diuretic, meant to treat bloating, apparently a xanthine and unsettlingly difficult to research, might not be a great idea if you're very sensitive to caffeine but honestly I couldn't say for sure.

1 tablet (4mg) chlorphenamine maleate - antihistamine, sedating, anticholinergic. The actual thing in Pamprin is pyrilamine maleate, but best I can tell that's not available by itself, and chlorphenamine seems to be the closest cousin. There's also no evidence that antihistamines actually help pms symptoms, so feel free to just skip it.

Pamprin Max Pain + Energy

One extra-strength (500mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

Note: This is literally just Excedrin, pink edition. Also it contains 2 common allergens (red 40 and coconut oil) that Excedrin does not.

Midol Complete (per tablet)

One extra-strength (500mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 cup of black or green tea OR half a cup of brewed coffee OR a coffee drink with 1 shot of espresso OR 1tsp instant coffee crystals (you can turn it into liquid coffee or not) OR one quarter a standard caffeine pill OR a half 100mg caffeine pill if you can find them. 50-100 mg of caffeine. Stimulant, vasoconstrictor, diuretic, increases heart rate, iirc works synergistically with the pain relievers.

1 tablet (4mg) chlorphenamine maleate - antihistamine, sedating, anticholinergic. The actual thing in Midol Complete is pyrilamine maleate, but best I can tell that's not available by itself, and chlorphenamine seems to be the closest cousin. There's also no evidence that antihistamines actually help pms symptoms, so feel free to just skip it.

Coricidin HBP Cold and Flu (per 2 tablet dose)

Two regular (325 mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 tablet (4mg) chlorphenamine maleate - antihistamine, sedating, anticholinergic.

Coricidin HBP Cough and Cold

1 tablet (4mg) chlorphenamine maleate - antihistamine, sedating, anticholinergic.

2 gel caps (15mg each, 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

Note: dextromethorphan by itself is a right pain to find these days. If you tolerate guaifenesin, a single tablet of 30mg dextromethorphan and 600mg guaifenesin will serve your purposes as well as or better than dextromethorphan by itself.

Coricidin HBP Cough, Cold, and Flu

Two regular (325 mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

1 or 2 gel caps (15mg each, 15 or 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 half tablet (600mg/tablet, 300mg total) guaifenesin - mucus thinner.

Note 1: this stuff contains 20mg dextromethorphan per dose, which doesn't seem to exist elsewhere. If you have a bad cough, take 2 15s, if you have a mild or occasional cough, take 1, if you don't have a cough, keep 1 handy but don't take it if you don't need it.

Note 2: there's 400mg of guaifenesin in a normal dose of Coricidin Cough, Cold & Flu, but tablets below 600mg are hard to find. 600mg is probably fine. You can also replace the dextromethorphan gels and guaifenesin tablet with a whole or half tablet of dextromethorphan 30mg/guaifenesin 600mg.

Coricidin Nighttime

Two regular (325 mg) paracetamol/acetaminophen (Tylenol) - non-NSAID pain reliever and fever reducer, hard on liver.

2 gel caps (15mg each, 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 half tablet (25mg per tablet, 12.5mg total) doxylamine succinate (unisom sleep tabs) - sleep aid, antihistamine, anticholinergic, dehydrating.

Note 1: See note on Coricidin Cough and Cold for more on dextromethorphan logistics

Note 2: Please take 25mg diphenhydramine hcl instead of the doxylamine succinate.

Coricidin Chest Congestion and Cough

1 or 2 gel caps (15mg each, 15 or 30mg total) dextromethorphan - cough suppressant, nmda receptor antagonist, histaminergic for some people.

1 half tablet (600mg/tablet, 300mg total) guaifenesin - mucus thinner.

Note: strictly speaking, this is 2/3 of a tablet of dextromethorphan 30mg/guaifenesin 600mg, so if you're good at cutting pills that's another option.

I feel like I'm missing an entire category of combination meds here. Please let me know if there's something else on which you'd like to see this kind of breakdown.

0 notes

corarenner · 8 months ago

Text

Cyclobenzaprine

Cyclobenzaprine is a medication primarily prescribed to alleviate muscle spasms and associated discomfort. It belongs to a class of drugs called skeletal muscle relaxants, which work by blocking nerve impulses or pain sensations that are sent to the brain. Commonly marketed under the brand names Flexeril and Amrix, Cyclobenzaprine is available in tablet and extended-release capsule forms. This article aims to shed light on what Cyclobenzaprine is, its potential side effects, and interactions with other substances.

What Is Cyclobenzaprine?

Cyclobenzaprine is utilized as a short-term treatment for muscle spasms caused by various conditions such as strains, sprains, or injuries. It's often prescribed alongside rest and physical therapy to enhance recovery. The medication helps to relieve muscle stiffness and discomfort, thereby improving mobility and promoting healing.

Side Effects of Cyclobenzaprine:

While Cyclobenzaprine is generally well-tolerated, like any medication, it can cause side effects in some individuals. Common side effects may include:

Drowsiness: Cyclobenzaprine can induce drowsiness and impair cognitive function. It's advised not to operate heavy machinery or drive until you know how this medication affects you.

Dry mouth: Some people may experience a dry mouth sensation while taking Cyclobenzaprine.

Dizziness: Feeling dizzy or lightheaded is another common side effect, especially when rising from a sitting or lying position.

Fatigue: Cyclobenzaprine may cause fatigue or weakness, impacting daily activities.

Blurry vision: Some individuals may experience temporary blurry vision while taking this medication.

Constipation: Cyclobenzaprine can lead to constipation in some people.

It's important to note that these side effects are usually mild and temporary. However, if they persist or worsen, it's advisable to consult a healthcare professional.

Interactions with Other Substances:

Cyclobenzaprine may interact with certain medications or substances, potentially altering their effects or increasing the risk of adverse reactions. It's essential to inform your healthcare provider about all the medications, supplements, or herbal products you're taking before starting Buy Cyclobenzaprine. Some substances that may interact with Cyclobenzaprine include:

Monoamine oxidase inhibitors (MAOIs): Combining Cyclobenzaprine with MAOIs can lead to serious and potentially life-threatening reactions such as high blood pressure, hyperthermia, and seizures.

Central nervous system depressants: Concurrent use of Cyclobenzaprine with other central nervous system depressants such as alcohol, benzodiazepines, or opioids may increase the risk of excessive sedation and respiratory depression.

Anticholinergic drugs: Combining Cyclobenzaprine with other medications possessing anticholinergic properties can enhance the risk of side effects such as dry mouth, constipation, and urinary retention.

To mitigate the risk of interactions, healthcare providers may adjust dosages or monitor patients closely when prescribing Cyclobenzaprine alongside other medications.

Cyclobenzaprine is a valuable medication for managing muscle spasms and associated discomfort. While it can be effective, it's essential to be aware of its potential side effects and interactions with other substances. By understanding how Cyclobenzaprine works and taking necessary precautions, individuals can safely benefit from its therapeutic effects. However, always consult a healthcare professional for personalised advice and guidance regarding its use.

Read More Website: https://www.buycyclobenzaprinemedication.com/

0 notes

unibytekids · 8 months ago

Text

List of Top Pediatric Companies In India

In a country such as India where the majority of the population is young, taking care of the health of children is very important, Pediatric PCD Pharma Franchise Company in India creates a significant impact on the future of the nation. These Top Pediatric PCD Pharma Franchise Companies continuously create great and highly efficient products for better growth of the children. They are providing premium quality and bulk quantity, for various and several reasons. Because our youth is our future, it is important to provide them with the best.

Here we will look at the Top Pediatric PCD Pharma Franchise Company in India. We will also look at the products, services, and criteria used to choose the best pediatric pharmaceutical companies in India. To select the best pediatric pharmaceutical company in India, we used the following criteria: Reputation, Years of Experience in the Industry, Quality of Products and Services, Customer Reviews and Contributions to pediatric healthcare. Only those companies that were able to excel in these criteria made it to the top 5. In recent years, there has been a lot of growth in the pediatric healthcare industry and several companies have emerged as leaders in the field.

Top 5 Pediatric PCD Pharma Franchise Companies in India.

Here we are with the list of best and top Pediatric Companies in India, these companies are well-reputed and highly experienced in pediatric range pharmaceuticals. If you are interested in starting your own Pediatric Pharmaceutical Business, this list can help you a lot.

# 1. - Unibyte Kids

As an authentic Pediatric PCD Pharma Franchise company in India, Unibyte Kids only offers high-quality products. All the products offered by the company are formulated and manufactured by the top paediatricians in the country. Since the products are intended to be used by children, we ensure that all formulations are safe to consume and have no adverse effects. Our manufacturing plants are equipped with the latest technology and machinery, allowing us to produce high-quality, safe and secure products. We offer a wide variety of products in various segments, such as:

Anticholinergics/antispasmodics Drops

Anti-Ulcer Medicines

Cholecalciferol/ Vitamin D3 Drops

Digestive enzymes Pharmaceuticals

Anti-inflammatory Medicines

Multivitamin Drops

Anti-Cold & Cough Syrup

Hematinic/Folic Acid (Oral) Products

Worm Medicine (Anthelmintics)

Antibiotic Syrups

Some of the perks of collaboration with Unibyte Kids for Pediatric PCD Pharma Franchise are:

Monopoly Rights

Better Return on Investments

Quality Assured Products

Quick Delivery

WHO, ISO, and GMP-certified products

24/7 Customer Supports

Name - Unibyte Kids

Address - Plot no: 158, Industrial Area, Phase:1 Panchkula Haryana 134311

Phone no - +91-9816857058

Email address - [email protected]

# 2. - Sonika Lifesciences

Sonika Lifesciences is one of the leading pharmaceutical companies in the pediatric sector. It manufactures, trades, and exports a wide variety of pediatric medicines. It offers a variety of medicines, including dietary supplements, syringes and capsules, tablets and ointments, as well as creams and gels powders and injections. All the medicines processed by Sonika Lifesciences are manufactured using the highest quality raw materials.

Address – SCO - 404, 1st Floor, Motor Market, Manimajra, Chandigarh, Punjab, India, Pin – 160101

# 3. - Nimbles Biotech

Nimbles Biotech comes in the top 5 pediatric companies in India today. The company has made a lot of scientific progress to improve the quality of life of its patients. The company’s medicines have successfully treated many types of life-threatening Infections. However, lifestyle diseases are still present, which continues to challenge the innovation and penetration of the healthcare industry. Nimbles Biotech is well experienced and prepared for such situations.

Address – Plot Number - 14, Arjun Nagar, Nanhera, Ambala Cantonment, Haryana, India, Pin – 134003

# 4. - Mestra Pharma

Discover the vast team of experts, scientists, and enthusiasm to overcome healthcare challenges by providing high-quality medicines and solutions. As one of the top Pediatric PCD Pharma Franchise companies in India, Mestra Pharma is making an impact on the lives of its patients through its diverse and innovative formulation range.

Address – A - 401, Empire Business Hub, Science City Road, Sola, Ahmedabad, Gujarat, India, Pin – 380060

# 5. - Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is a world-renowned pediatric pharmaceutical company that focuses on the extensive development of New Chemical Entities (NCEs) and New Biological Entities (NBEs). The company has a variety of molecules in various phases of pre-clinical and clinical development. Glenmark Pharmaceuticals focuses primarily on the field of Pediatric medicine.

Address – Glenmark Pharmaceuticals Ltd, B/2, Mahalaxmi Chambers, #22, Bhulabhai Desai Road, Mumbai, Maharashtra, India, Pin – 400026

Conclusion

The demand for pediatric medicinal products in India is very high due to the growing number of newborn babies and children. The pediatric range in the pharmaceutical industry is the best range available. We hope you find this list of Best Pediatric Medicine Companies in India useful. It can assist you in selecting the Best Pediatric Company in India.

#pcdpharmafranchise #pediatrics #franchise #kidshealth #monopolybased #pcdpharma #children

0 notes

discoverybody · 9 months ago

Text

Connection between Tablets and Memory Loss

Tablets have become an essential part of our daily lives, yet there is growing concern about their impact on memory loss. While not all tablets cause memory problems, some have been linked to cognitive impairment. Benzodiazepines, which are often used to treat anxiety and sleep disorders, can cause memory loss when taken for an extended period of time or in large dosages. Similarly, anticholinergic medications, which are used to treat allergies and bladder problems, can impair memory by suppressing the neurotransmitter acetylcholine.

Several research have investigated the relationship between tablet use and memory decline. Long-term usage of benzodiazepines has been linked to an increased risk of dementia. Similarly, long-term usage of anticholinergic medications has been associated to an increased incidence of dementia in older adults. However, these studies simply indicate a connection; additional research is required to determine causation and the particular processes by which tablets alter memory performance.

#tablet #benefits #memory loss #tablets cause memory loss #healthcare

0 notes

meghanester · 1 year ago

Text

Scopolamine Market 2023-2035 to Expand at a CAGR of ~5% Assessment | Revenue, Segments, Expansion, Demand, and Opportunities

Global Scopolamine Market Key Insights

During the forecast period of 2023-2035, the global scopolamine market is expected to reach an estimated value of ~USD 830 billion by 2035, by expanding at a CAGR of ~5%. The market further generated a revenue of ~USD 462 billion in the year 2022. Major key factors propelling the growth of scopolamine market worldwide are the proliferating investment in the pharmaceutical sector for the development of neurotherapeutics drugs that can contribute to the prevention of nausea and vomiting caused by recovery from anesthesia and surgery along with the surging number of surgeries worldwide.

Market Definition of Scopolamine

Scopolamine, with chemical formula C17H21NO4, is a poisonous alkaloid which is used for its anticholinergic effects. The drug is used to prevent nausea and vomiting caused by motion sickness or medications that are used during surgery. It is also used to treat certain stomach or intestinal problems, muscle spasms, and Parkinson-like conditions. Scopolamine works by blocking the effects of a certain natural substance known as acetylcholine on the central nervous system and it falls in a class of medications called antimuscarinics.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-3312

Global Scopolamine Market: Growth Drivers

The growth of the global scopolamine market can majorly be attributed to the number of people suffering from mental disorders such as anxiety and depression with the rising use of scopolamine as an antidepressant and antianxiety drug. According to the Anxiety and Depression Association of America, anxiety disorders affect 40 million adults in the United States, or 18.1% of the population every year, and are the most common mental illness in the country. On the other hand, the market growth can also be attributed to the increasing number of travelers where around 1 in 3 people are considered highly susceptible to motion sickness along with the growing demand for medication used to manage motion sickness which is also projected to drive the market growth.

The global scopolamine market is also estimated to grow majorly on account of the following:

Rising investment in the healthcare sector

Increasing burden of diseases along with growing demand for antianxiety drugs owing to rising stress

Rising prevalence of the musculoskeletal disorder

Growing number of surgical interventions globally

Global Scopolamine Market: Restraining Factor

There are various severe side effects as well as withdrawal symptoms associated with the usage of scopolamine. Additionally, the prolonged use of transdermal scopolamine can lead to drug-dependent addiction. Hence, this factor is expected to be the major hindrance to the growth of the global scopolamine market during the forecast period.

Request for customization @ https://www.researchnester.com/customized-reports-3312

Global Scopolamine Market Segmentation

By Dosage Form (Tablet, Syrup, Injection, Patch, and Others)

The patch segment, amongst all the other segments, is anticipated to garner the largest revenue by the end of 2035. Nowadays, scopolamine patches are widely adopted to treat nausea and vomiting post-surgery. These patches are highly preferred owing to their cost-effectiveness, rising availability, and ease of use. With the surge in the number of major surgeries that are performed each year reaching nearly 310 million, the segment for patches is projected to garner the largest share over the forecast period.

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

By Region

The North America scopolamine market is anticipated to hold the largest market share by the end of 2035 among the market in all the other regions. The major factor anticipated to drive the growth of the market in North America during the forecast period is the rising demand for medication used to manage motion sickness in the region owing to the surge in traveling instances and the number of travelers in the region. For instance, domestic travel in the U.S. increased by 1.9% in 2018, which is a total of 2.3 billion-person trips, as per the reports of the U.S. Travel Association.

The market research report on global scopolamine also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Key Market Players Featured in the Global Scopolamine Market

Some of the key players of the global scopolamine market are Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co. Ltd., Alchem International Pvt. Ltd., Caleb Pharmaceuticals, Inc., GlaxoSmithKline plc, Phytex Australia, Fine Chemicals Corporation, Perrigo Company plc, Novartis International AGand others.

Obtain this Report @ https://www.researchnester.com/reports/scopolamine-market/3312

About Research Nester

Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: [email protected]

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

#Scopolamine Market

0 notes

janeblr · 2 years ago

Text

OKAY so I went through a phase after my grandma died where I was constantly high on Benadryl so I can talk about this!

At LOW doses, like 25-50 or 1-2 tablet, it makes you sleepy and treats your allergy symptoms. This is the intended use and safe dosage for an adult.

At doses higher than that, it’s a deliriant, causing anxiety, tactile/auditory/visual hallucinations that you cannot differentiate from reality, a very unpleasant body high, muscle spasms, dizziness, and difficulty thinking. It’s a universally unpleasant experience.

Also, since benadryl is an anticholinergic, your mouth gets dry as fuck, you can’t pee, and you can’t shit.

You ever heard of the Hatman? People joke about him, but he’s a real and common hallucination. A menacing presence near you that you cannot distinguish from reality.

Benzos can be used to lessen the effects of Benadryl overdose, but it’s unpredictable and mixing drugs is always risky so this needs to be done in a medical setting.

when u guys from the us take benadryl is it like recreationally? like is it fun. or does it just make u sleep. even if it just makes u sleep how many do u take for it to make u sleepy is it one enough

18 notes · View notes

medicalnewsearthy01 · 1 year ago

Text

Phenergan Medicine for Nausea:

Phenergan, also known by its generic name promethazine, is a medication commonly used to treat nausea and vomiting. It belongs to a class of drugs known as antihistamines and antiemetics. Phenergan is available in various forms, including tablets, suppositories, and syrups. It works by blocking certain receptors in the brain that trigger the sensation of nausea and vomiting, making it an effective option for managing these symptoms.

Mechanism of Action:

Phenergan primarily exerts its effects through several mechanisms:

Histamine Blockade: Phenergan is an antihistamine, which means it blocks the action of histamine, a chemical released in the body in response to various stimuli, including allergens and irritants. Histamine can trigger nausea and vomiting by stimulating certain receptors in the brain. By inhibiting histamine's effects, Phenergan helps reduce the sensation of nausea.

Dopamine Antagonism: Phenergan also has an antagonistic effect on certain dopamine receptors in the brain, particularly in the chemoreceptor trigger zone (CTZ). The CTZ is an area of the brain that plays a crucial role in triggering the vomiting reflex. By blocking dopamine receptors in the CTZ, Phenergan helps to prevent nausea and vomiting.

Anticholinergic Effects: Phenergan exhibits mild anticholinergic properties, which means it can reduce the activity of acetylcholine, a neurotransmitter that plays a role in various bodily functions. These effects can contribute to the medication's antiemetic (anti-vomiting) properties.

Indications:

Phenergan is primarily prescribed for the treatment of various conditions associated with nausea and vomiting, including:

Motion sickness

Nausea and vomiting due to surgery or medical procedures

Nausea and vomiting caused by chemotherapy

Gastroenteritis (stomach flu)

Migraine-associated nausea

Postoperative nausea and vomiting

Dosage and Administration:

The dosage of Phenergan varies depending on factors such as the patient's age, the severity of symptoms, and the form of the medication. It is available in oral tablet, rectal suppository, and syrup forms. The dosage instructions should be closely followed as prescribed by a healthcare professional.

Precautions and Side Effects:

Phenergan is generally well-tolerated, but like any medication, it can have potential side effects. Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, and constipation. In some cases, it can cause more serious side effects like allergic reactions, difficulty breathing, and abnormal heart rhythms. Due to its potential to cause drowsiness, patients are advised not to operate heavy machinery or drive while taking Phenergan.

Interactions:

Phenergan can interact with other medications, especially those that cause central nervous system depression, such as alcohol, sedatives, and tranquilizers. It's important to inform your healthcare provider about all the medications you're taking to avoid potential interactions.

Conclusion:

Phenergan (promethazine) is a medication commonly used to alleviate nausea and vomiting. It works by blocking histamine receptors, antagonizing dopamine receptors in the CTZ, and exerting mild anticholinergic effects. This combination of mechanisms makes it effective in managing various causes of nausea and vomiting. However, like all medications, it should be used under the guidance of a healthcare professional to ensure safety and effectiveness.

#medicine #health #nausea

0 notes

allergostore · 3 years ago

Text

1. Name of the therapeutic product

TAVEGIL TABLETS

2. Quantitative and qualitative composition Clemastine hydrogen fumarate 1.34mg (equivalent to clemastine base 1mg)

For excipients see 6.1

3. Pharmaceutical form White, uncoated, round, seven mm in diameter with beveled edges, easy on one side and also marked with "OT" and also scored with one breakline on the other person.

4. Clinical particulars 4.1 Therapeutic indications Allergic rhinitis, such as perennial rhinitis and hay fever, vasomotor rhinitis.

Allergic dermatoses, which includes pruritus, atopic eczema and also contact dermatitis.

Urticaria. Angioneurotic oedema, drug allergy.

4.2 Posology plus technique of administration Adults

1mg clemastine base (one tablet) evening and early morning.

In specific cases the dose might be elevated to 6mg clemastine base every day if needed (six tablets).

Children

One to three years: 250 microgrammes to 500 microgrammes clemastine base (¼ - ½ tablet evening and morning.

Three to six years: 500 microgrammes clemastine base (½ tablet) evening and early morning.

Six to twelve years: 500 microgrammes to thousand microgrammes clemastine base (½ - one tablet) evening and early morning.

Take in the elderly

Absolutely no evidence exists that elderly individuals call for unique dosages or even show various side effects from young people.

Oral administration only.

Maximum length of use: Clemastine fumarate shouldn't be used for over fourteen days without consulting a physician. Don't exceed the suggested dose

4.3 Contraindications Tavegyl is contraindicated in individuals with a recognized hypersensitivity to clemastine or maybe other arylalkylamine antihistamines, and the excipients.

TAVEGIL shouldn't be provided to porphyric patients.

TAVEGIL shouldn't be provided to kids below a single year of age.

4.4 Special precautions and alerts for use Antihistamines must be utilized with caution in individuals with:

• narrow-angle glaucoma

• stenosing peptic ulcer

• pyloroduodenal obstruction

• prostatic hypertrophy with urinary bladder and also retention neck obstruction.

• kids as a result of the danger of excitability in this specific population (see area 4.8)

• epilepsy or perhaps history of seizures

• in the aged, who're far more apt to feel negative effects such as for instance paradoxical excitation. Stay away from use in patients that are elderly with confusion. Don't exceed recommended dosage plus duration of using without consulting a healthcare provider (See Administration and Dosage).

Tavegyl tablets include lactose. Patients with unusual hereditary issues of galactose intolerance, the Lapp lactose deficiency or maybe glucose galactose malabsorption shouldn't carry the medication.

4.5 Interaction with other therapeutic goods along with other types of interaction Antihistamines potentiate the sedative consequences of Central Nervous System (CNS) depressants including hypnotics, monoamine oxidase inhibitors (MAOI's), anxiolytics, antidepressants, opioid analgesics as well as alcohol.

Patients must be advised to stay away from alcoholic drinks.

As clemastine has several anticholinergic activity, the consequences of several anticholinergic medicines (e.g. atropine, tricyclic antidepressants) might be potentiated.

4.6 Fertility, and pregnancy lactation TAVEGIL shouldn't be provided during pregnancy and breast feeding.

4.7 Effects on power to drive and make use of machines TAVEGYL has reasonable impact on the capacity to drive and make use of devices, as a result of the antihistamine sedative impact of clemastine, nonetheless, people must be warned to not take charge of machinery or maybe vehicles until the result of TAVEGIL therapy on the person is known.

Address: Tesselsestraat 90 Den Haag, 2583 JM

Mob: 06-62712398

youtube

1 note · View note

credenceresearchdotblog · 3 months ago

Text

The Hydroxyzine Market is projected to grow from USD 824.62 million in 2024 to USD 1,261.69 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.46%.The global pharmaceutical landscape is vast and dynamic, with various segments witnessing growth driven by innovation, demand, and changing consumer health needs. One such segment is the Hydroxyzine market. Hydroxyzine, an antihistamine with anticholinergic and sedative properties, is primarily used to treat allergy symptoms, anxiety, and nausea, and as a preoperative sedative. This article explores the current state of the Hydroxyzine market, its growth drivers, challenges, and future outlook.

Browse the full report at https://www.credenceresearch.com/report/hydroxyzine-market

Market Overview

Market Drivers

Several factors contribute to the growth of the Hydroxyzine market:

Challenges Facing the Market

Despite its growth prospects, the Hydroxyzine market faces several challenges:

Future Outlook

Key Player Analysis

Novartis AG

Piramal Group (Piramal Healthcare UK Limited)

GSK, plc

N&R Industries

Pfizer, Inc.

Teva Pharmaceuticals

Shanghai Ruizheng Chemical Technology Co., Ltd

Impax Laboratories, Inc

Alliance Pharma PLC

Segments:

Based on Dosage Form:

Tablets

Capsules

Injections

Syrup

Based on Indication Type:

Histamine-mediated pruritus

Urticaria

Atopic contact dermatitis

Based on the Geography:

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/hydroxyzine-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

prostaplexreviews98-blog · 4 years ago

Text

How An Enlarged Prostate (BPH) Impacts Your Bladder

When you're a man and you reside lengthy enough, you will virtually definitely develop benign prostatic hyperplasia (BPH). Mirabegron (Betmiga®). If anticholinergics aren't working, or you can't take anticholinergics, your physician may advocate attempting mirabegron tablets. Mirabegron is a new type of drug known as a beta-three-adrenoceptor agonist. It will possibly help if it's essential urinate more often than traditional or get sudden urges to urinate. Attainable side effects embody hypertension, urine infections and complications. There are several completely different remedies for this problem, based in your symptoms. These embrace anti-inflammatory medicines and different pain management remedies, corresponding to warm baths. Different medicines, such as alpha-blockers, may be given. Alpha-blockers loosen up muscle tissue within the prostate to make passing urine simpler. Some males are handled with antibiotics in case the symptoms are brought on by an undetected infection.

Is ProstaPlex The Pure Strategy to Relieve BPH?

ProstaPlex is an all-pure dietary complement that fights innate immuno-irritation, which is responsible for causing benign prostatic hyperplasia (BPH), with superfoods guarded by the men of small Japanese villages for centuries. The spokesperson of the manufacturing firm, Kevin Meadows, claims that this pill is more practical than commonly prescribed therapies and invasive surgical procedures because Prosta Plex ingredients are Lycopene, Beta-Sitosterol, Zinc Oxide, Pumpkin Seed Extract, and Saw Palmetto Berries which sown to help naturally individuals affected by an enlarged prostate. On this What is ProstaPlex we'll see if this product elements will assist or not people suffering from an enlarged prostate.

Each man's experience with BPH is completely different. Signs may be steady, may come and go, or might turn out to be more bothersome over time. Some men find the signs to be mild and don't require remedy with medicines. Other males find the symptoms bothersome and select therapy with medicine or, less commonly, surgical procedure.

#prostaplex

1 note · View note

mcatmemoranda · 5 years ago

Text

Second-generation antipsychotics (SGAs), also known as atypical antipsychotics, generally have lower risk of extrapyramidal side effects and tardive dyskinesia compared with first-generation antipsychotics (FGAs).

FGAs and SGAs have comparable efficacy. The SGA, clozapine, has the best efficacy, but due to its adverse effects, it is used for schizophrenia that is treatment- refractory.

Antipsychotics work by blocking the postsynaptic D2 receptor. Aripiprazole and brexpiprazole are partial D2 receptor agonists. Cariprazine is a D2/D3 receptor partial agonist, with preference for D3. Pimavanserin is a serotonin 5HT2A inverse agonist and antagonist with no dopamine D2 affinity. Antipsychotics have to bind 65% of dopamine receptors to have antipsychotic efficacy in functional imaging studies.

Unlike FGAs, SGAs also bind 5HT2 receptors, which may be part of the reason why SGAs have lower risk for EPS. SGAs may also bind more loosely to D2 receptors and preferentially block receptors in the limbic and cortical regions rather than in the striatal areas. SGAs also bind muscarinic, alpha-adrenergic, and histaminic receptors, which causes their side effects.

In urgent situations, rapidly absorbed antipsychotics are used. Sublingual asenapine is the most rapidly absorbed, with a one-hour time to peak serum concentration, followed closely by lurasidone and the immediate-release formulation of quetiapine.

Drugs that are absorbed more slowly such as olanzepine, ziprasidone, and extended release quetiapine, are better tolerated. Lurasidone and ziprasidone should be taken with a meal, as this enhances bioavailability. A high fat meal increases absorption of quetiapine by 50%. It’s recommended not to take quetiapine with a high fat meal.

Most antipsychotics are metabolized through the cytochrome P450 system in the liver. Paliperidone (the active metabolite of risperidone) is mostly excreted unchanged by the kidneys, so dose adjustment is not required in pts with liver impairment. But of course, dose adjustment of paliperidone is required in pts with kidney dysfunction; and palliperidone is C/I in pts with renal impairment.

People with CYP2D6 polymorphisms may be slow or fast metabolizers of certain antipsychotics, which is why serum levels of drugs are assessed if poor or extensive metabolism is suspected.

In poor metabolizers, dose reductions of 50 percent have been recommended for aripiprazole, brexpiprazole, and iloperidone; dose reduction is also recommended for poor metabolizers of clozapine.

Because aripiprazole is a partial agonist of D2 receptors, it may counteract the effects of other SGAs that primarily block the D2 receptor. So you may see a paradoxical decrease in antipsychotic effect as the dose of aripiprazole is increased when switching from an antipsychotic with D2 receptor blockade effect. Abilify is metabolized by CYP 2D6 and 3A4. So dose adjustments should be made when the pt is concurrently taking drugs that either inhibit or increase activity of these enzymes. The manufacturer recommends a twofold dose increase of Abilify in the presence of metabolic inducers such as carbamazepine and a 50 percent reduction in dose with inhibitors such as fluoxetine, quinidine, or ketoconazole.

CYP3A4 inducers, such as rifampin, decrease the levels of brexpiprazole and aripiprazole.

Clozapine is metabolized via CYP1A2, 2D6, and 3A4. Fluvoxamine and ciprofloxacin inhibit CYP1A2 and thus require reduced dosing of clozapine if the pt is on these medications concurrently.

Clozapine can cause agranulocytosis. It also causes strong anticholinergic, sedative, cardiac, and hypotensive effects, so drugs with the same side effects should not be combined with clozapine.

Olanzepine is metabolized by CYP 1A2 and has fewer drug-drug interactions, but of course drugs that induce or inhibit CYP1A2 should be avoided with olanzepine use.

Polycyclic aromatic hydrocarbons in tobacco smoke may induce CYP1A2, so olanzepine dose may need to be adjusted in smokers when they’re in non-smoking facilities and when they are outpatient.

Pimavanserin is metabolized by CYP3A4 and should be avoided with drugs that prolong the QT interval.

Quetiapine is metabolized by CYP 3A4, and the manufacturer recommends up to a fivefold increase in dose with inducers such as carbamazepine and a reduction to one-sixth the dose with strong CYP3A4 inhibitors such as voriconazole or ritonavir.

Side effects may worsen when the drug is combined with other agents that cause sedation, anticholinergic effects, hypotension, or weight gain.

Risperidone serum levels are increased by strong CYP2D6 inhibitors such as fluoxetine and paroxetine, and to a lesser degree by bupropion.

Ziprasidone is metabolized via glutathione and aldehyde oxidase, with a minor contribution from CYP 3A4. It can cause prolonged QT interval, especially when combined with other medications that prolong the QT interval.

Aripiprazole, asenapine, clozapine, olanzapine, and risperidone are available in oral disintegrating tablets, which are useful in pts who cheek their medications or in those with dysphagia.

For emergent situations, rapid release olanzepine and ziprasidone can be given intramuscularly. No SGAs can be given intravenously. In a previous presentation on antipsychotics, I think there was a question about that. So remember that olanzepine and ziprasidone can be given IM.

Long-acting, injectable antipsychotics are used to treat patients unable to adhere to daily regimens. Long-acting versions of aripiprazole, olanzapine, paliperidone, and risperidone may be administered by injection at two-week to three-month intervals.

Oral dosing of SGAs with standard or orally disintegrating tablets is the preferred route of administration in most patients. These formulations have equivalent dosing, absorption, and clearance.

Dosing at bedtime is generally preferred because of the sedation associated with many of these drugs, but exceptions are common and the medications work equally well irrespective of the time of the dose.

Common side effects associated with second-generation antipsychotics (SGAs) include weight gain and related metabolic effects, hypotension, sedation, anticholinergic symptoms, hyperprolactinemia, extrapyramidal symptoms (EPS), cardiac effects, cardiomyopathies, cataracts, and sexual dysfunction.

Take into account pt medical conditions when choosing an antipsychotic to use. For example:

●A patient whose symptoms include insomnia may benefit from a sedating antipsychotic. What antipsychotic causes sedation? Answer: quetiapine (seroquel).

●A patient with diabetes should avoid medications with a high risk of weight gain and metabolic effects. What antipsychotic is known for causing metabolic syndrome? Answer: olanzepine.

●A patient with a known cardiac problem or taking medications that prolong QT interval should preferentially receive an antipsychotic with a more favorable cardiac profile. What antipsychotic prolongs the QT interval? Answer: ziprasidone.

●A patient with essential hypertension may do well with an antipsychotic with hypotensive effects.

Rare but serious side effects include tardive dyskinesia, neuroleptic malignant syndrome, seizures, agranulocytosis, hypersensitivity reactions, and an increased risk of mortality from all causes, especially in older adult patients with dementia-related psychosis.

Weight gain, diabetes, and dyslipidemia are the components of metabolic syndrome usually associated with SGAs, along with the consequent risks of diabetic ketoacidosis and cardiovascular disease.

Clozapine and olanzapine carry significantly higher risk for metabolic syndrome than other antipsychotics, whereas aripiprazole, lurasidone, pimavanserin, and ziprasidone are associated with the lowest risk.

The potential morbidity of these symptoms has led to recommendations for routine short- and long-term monitoring of weight, waist circumference, blood pressure, fasting glucose, and lipid profile of patients taking any of the antipsychotic drugs.

Anticholinergic effects of antipsychotics include dry mouth, constipation, blurred vision, and urinary retention. Clozapine causes sialorrhea. Otherwise, it has the strongest anticholinergic effects.

regular inquiries regarding urinary retention, blurred vision, and especially constipation should be made. Aggressive treatment of constipation, often including prophylactic agents, may be required to avoid serious side effects, such as fecal impaction or bowel perforation.

Sources:

https://www.ncbi.nlm.nih.gov/pubmed/10427467

https://www.uptodate.com/contents/second-generation-antipsychotic-medications-pharmacology-administration-and-side-effects?search=antipsychotics&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

#antipsychotics

7 notes · View notes